Clinical Trial

Microparticles Blood Level in Acute Carbon Monoxide Poisoning

Study acronym: COMPs
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 14, 2024 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this pilot, clinical, experimental, biological and prospective study with uso of biological material (venous blood sampling), in patient with acute carbon monoxide (CO) intoxication and in a group of healthy non-intoxicated subject (group of control) is the research of a possible increase of circulating microparticles level in human blood with an acute carbon monoxide intoxication. The main question to answer is: Is there an increase of circulating microparticles levels in subjects with acute carbon monoxide poisoning? Two blood samples will be withdrawn from patients with acute carbon monoxide poisoning, one before and one after hyperbaric oxygen treatment. Researchers will compare a group of healthy volunteers to see if there is a different in circulating microparticles blood level compared to patients with intoxication.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-10-19; most recent amendment 2024-11-13.
Status change: Not Yet Recruiting → Recruiting 2023-01-31
Trial Details
NCT Number NCT05591300
Lead Sponsor Azienda Ospedaliero Universitaria Maggiore della Carita
Collaborators: Università degli Studi del Piemonte Orientale Amedeo Avogadro
Conditions Carbon Monoxide Poisoning
Enrollment 108 participants
Start Date 2022-11-15
Primary Completion 2025-04 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2024-11-14